acetylglucosamine has been researched along with Alloxan Diabetes in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.11) | 18.7374 |
| 1990's | 1 (2.70) | 18.2507 |
| 2000's | 9 (24.32) | 29.6817 |
| 2010's | 23 (62.16) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, X; Hu, L; Huang, X; Luo, L; Tao, M; Wu, M; Wu, Y; Yang, L; Zhou, Z | 1 |
| Chen, GS; Chiu, MH; Huang, SM; Lan, CE; Wu, CS; Yang, HJ | 1 |
| Liu, Z; Long, Y; Luo, S; Xia, Y; Yan, J | 1 |
| Casteel, DE; Castillo, F; Dillmann, W; Kalyanaraman, H; Pilz, RB; Ramdani, G; Sah, RL; Schwaerzer, G; Scott, BT | 1 |
| Cao, Q; Chen, Q; Chen, S; Fu, L; Hong, K; Hu, J; Hu, L; Huang, L; Jin, J; Liu, X; Shen, Y; Wan, R; Xie, J; Xu, Z; Yan, X; Yu, J; Yu, P; Yuan, P; Zhou, Q; Zhu, W | 1 |
| Ding, F; Fu, G; Wang, M; Xia, Q; Xu, S; Yu, L | 1 |
| Bradley, WE; Chatham, JC; Chen, Y; Dell'Italia, LJ; Heath, JM; Litovsky, S; Sun, Y; Wu, H; Yuan, K | 1 |
| Choi, JH; Han, HJ; Kim, DI; Lim, SK; Park, MJ; Park, SH; Yoon, KC | 1 |
| Aikawa, E; Rogers, MA | 1 |
| Aveta, T; Barutta, F; Bellini, S; Bruno, G; Corbelli, A; Di Marzo, V; Franco, I; Gambino, R; Grimaldi, S; Gruden, G; Hirsch, E; Pinach, S; Rastaldi, MP | 1 |
| Caceres, V; Chakir, K; Cole, RN; DeVine, L; Gao, WD; Hart, GW; Lugo-Fagundo, NS; Ma, J; Marchionni, L; Murphy, AM; Paolocci, N; Ramirez-Correa, GA; Shen, X; Slawson, C; Xu, M; Zeidan, Q | 1 |
| Wende, AR | 1 |
| Balogh, D; Banki, NF; Fekete, A; Fulop, N; Gellai, R; Hodrea, J; Hosszu, A; Koszegi, S; Lenart, L; Molnar, A; Szabo, AJ; Vannay, A; Ver, A; Wagner, L | 1 |
| Banerjee, P; Costello, CE; Hart, GW; Liu, T; Ma, J; McComb, ME; Murphy, A; O'Rourke, B; Ramirez-Correa, G; Wei, AC; Whelan, SA | 1 |
| Du, H; Han, P; Li, S; Shao, M; Song, G; Sun, H; Wang, W; Yi, T | 1 |
| Anthonisen, EH; Berven, L; Grønning-Wang, LM; Holm, S; Nebb, HI; Nygård, M | 1 |
| Jia, R; Tu, Y; Wu, G | 1 |
| Asahi, M; Miyoshi, E; Otsu, K; Suzuki, K; Takeda, T; Taniguchi, N; Yokoe, S | 1 |
| Jung, O; Kang, M; Kim, H; Kim, HJ; Kim, SH; Kwak, TK; Lee, JW; Lee, SA; Park, JM | 1 |
| Bakker, SJ; Braunagel, M; Brinkkötter, P; Deinzer, M; Hammes, HP; Henning, RH; Koeppel, H; Krämer, BK; Navis, G; Pfister, F; Riedl, E; Sternik, P; van den Born, J; Yard, B | 1 |
| Aleksandra, U; Goran, P; Jelena, A; Jelena, M; Melita, V; Mirjana, M; Nevena, G; Svetlana, D | 1 |
| Joo, HJ; Kim, HS; Moon, WK; Woo, JS | 1 |
| Dillmann, W; Gawlowski, T; Han, X; Hoshijima, M; Schwappacher, R; Scott, B; Suarez, J; Torres-Gonzalez, M; Wang, H; Yates, JR | 1 |
| Arambašić, J; Bajec, D; Dinić, S; Grdović, N; Marković, J; Mihailović, M; Poznanović, G; Uskoković, A; Vidaković, M | 1 |
| Hascall, VC; Lauer, ME; Wang, A | 1 |
| Brownlee, M; Edelstein, D; Giardino, I; Hammes, HP; Matsumura, T; Pestell, R; Rabbani, N; Sarthy, VP; Suske, G; Taguchi, T; Thornalley, PJ; Yao, D | 1 |
| Luo, B; McClain, DA; Soesanto, Y | 1 |
| Alperovich, M; Chan, RK; Demcheva, M; Hechtman, HB; Kaipainen, A; Newalder, J; Orgill, DP; Pietramaggiori, G; Scherer, SS; Valeri, CR; Vournakis, JN; Yang, HJ | 1 |
| Crawford, GL; Hart, GW; Whiteheart, SW | 1 |
| Hart, GW; Housley, MP; Hunt, DF; Kelly, TJ; Puigserver, P; Rodgers, JT; Shabanowitz, J; Udeshi, ND | 1 |
| Chin, E; Kudlow, JE; Liu, K; Paterson, AJ | 1 |
| Konrad, RJ; Kudlow, JE; Liu, K; Mikolaenko, I; Tolar, JF | 1 |
| Brownlee, M; Dimmeler, S; Du, XL; Edelstein, D; Ju, Q; Sui, C | 1 |
| Malaisse, WJ; Ramirez, R; Zähner, D | 1 |
| Alberti, KG; Hawthorne, GC; MacLellan, JR; Mythen, M; Turner, GA | 1 |
| Caldwell, RB; Fitzgerald, ME | 1 |
| Kawada, J; Nishida, M; Toide, K; Tsujihara, K; Yoshimura, Y | 1 |
37 other study(ies) available for acetylglucosamine and Alloxan Diabetes
| Article | Year |
|---|---|
A non-anticoagulant heparin-like snail glycosaminoglycan promotes healing of diabetic wound.
Topics: Acetylglucosamine; Actins; Angiogenesis Inducing Agents; Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Experimental; Edema; Epithelium; Glycosaminoglycans; Heparin; Iduronic Acid; Inflammation; Interleukin-8; Magnetic Resonance Spectroscopy; Male; Mice; Platelet Endothelial Cell Adhesion Molecule-1; Regeneration; Skin; Skin Diseases; Snails; Wound Healing | 2020 |
High-glucose environment induced intracellular O-GlcNAc glycosylation and reduced galectin-7 expression in keratinocytes: Implications on impaired diabetic wound healing.
Topics: Acetylglucosamine; Animals; Cell Movement; Diabetes Mellitus, Experimental; Epigenesis, Genetic; Galectins; Glucose; Glycation End Products, Advanced; Glycosylation; Healthy Volunteers; Humans; Keratinocytes; Male; Mice; Mice, Hairless; Reactive Oxygen Species; RNA, Messenger; Skin; Streptozocin; Wound Healing | 2017 |
Measurement of O-GlcNAcylated endothelial nitric oxide synthase by using 2',5'-ADP-Sepharose pull-down assay.
Topics: Acetylglucosamine; Animals; Antibodies; Aorta, Thoracic; Cattle; Cells, Cultured; Chromatography, Affinity; Diabetes Mellitus, Experimental; Glycosylation; Immunoprecipitation; Male; Nitric Oxide Synthase Type III; Polysaccharides; Rats; Sepharose | 2017 |
Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.
Topics: Acetylglucosamine; Animals; Benzoates; Cell Proliferation; Cell Survival; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Feedback, Physiological; Glucose; Guanylate Cyclase; Hydrogen Peroxide; Insulin; Male; Mice; NADPH Oxidase 4; Nitric Oxide; Nitric Oxide Synthase Type III; Osteoblasts; Osteogenesis; Oxidative Stress; Proto-Oncogene Proteins c-akt; Signal Transduction | 2018 |
O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts.
Topics: Acetylglucosamine; Acylation; Animals; Arrhythmias, Cardiac; Diabetes Mellitus, Experimental; HEK293 Cells; Humans; Male; NAV1.5 Voltage-Gated Sodium Channel; Rats; Rats, Sprague-Dawley | 2018 |
O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Cardiomegaly; Cyclin D2; Diabetes Mellitus, Experimental; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glucose; Glycosylation; Heart; JNK Mitogen-Activated Protein Kinases; Male; Myocardium; Myocytes, Cardiac; N-Acetylglucosaminyltransferases; Oximes; p38 Mitogen-Activated Protein Kinases; Phenylcarbamates; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Small Interfering; Signal Transduction; Streptozocin | 2013 |
Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus.
Topics: Acetylglucosamine; Animals; Aorta; beta-N-Acetylhexosaminidases; Core Binding Factor Alpha 1 Subunit; Diabetes Mellitus, Experimental; Glycosylation; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Inbred C57BL; Multiprotein Complexes; Muscle, Smooth, Vascular; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; Pyrans; Thiazoles; TOR Serine-Threonine Kinases; Vascular Calcification | 2014 |
High glucose-induced O-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: the possible role in the development of diabetic nephropathy.
Topics: Acetylglucosamine; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta-N-Acetylhexosaminidases; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Gene Expression Regulation, Enzymologic; Glucose; HEK293 Cells; Humans; Lipogenesis; Mesangial Cells; Oximes; Phenylcarbamates; Rats; Sweetening Agents; Triglycerides | 2014 |
Modifying vascular calcification in diabetes mellitus: contribution of O-GlcNAcylation.
Topics: Acetylglucosamine; Animals; Diabetes Mellitus, Experimental; Proto-Oncogene Proteins c-akt; Vascular Calcification | 2014 |
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Topics: Acetylglucosamine; Albuminuria; Animals; Bone Marrow Transplantation; Cell Line; Cell Proliferation; Chemokine CCL2; Chemotaxis, Leukocyte; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix; Female; Kidney Glomerulus; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Podocytes; Receptor, Cannabinoid, CB2; Receptors, CCR2; Streptozocin; Time Factors | 2014 |
Removal of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Calcium; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gene Expression Regulation, Enzymologic; Humans; Male; Myocardium; Myofibrils; Rats; Rats, Sprague-Dawley; Sarcomeres | 2015 |
Unsticking the Broken Diabetic Heart: O-GlcNAcylation and Calcium Sensitivity.
Topics: Acetylglucosamine; Animals; Calcium; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Humans; Male | 2015 |
Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
Topics: Acetylglucosamine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cell Line; Cell Survival; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Glycosylation; HSP72 Heat-Shock Proteins; Humans; Kidney; Kidney Tubules, Proximal; Losartan; Male; Nitric Oxide Synthase Type III; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Renin-Angiotensin System; Signal Transduction | 2016 |
Comparative Proteomics Reveals Dysregulated Mitochondrial O-GlcNAcylation in Diabetic Hearts.
Topics: Acetylglucosamine; Acylation; Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Mitochondria; Mitochondrial Proteins; Myocardium; Proteomics; Rats; Tandem Mass Spectrometry | 2016 |
Astragaloside IV ameliorates renal injury in db/db mice.
Topics: Acetylglucosamine; Albuminuria; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Glycated Hemoglobin; Hypertrophy; Kidney; Lipocalin-2; Liver; Mice; Phosphorylation; Saponins; Signal Transduction; Transforming Growth Factor beta1; Triterpenes | 2016 |
Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose.
Topics: Acetylglucosamine; Animals; Cell Line, Tumor; Diabetes Mellitus, Experimental; Glucose; Glycosylation; Humans; Lipid Metabolism; Liver; Liver X Receptors; Male; Mice; Orphan Nuclear Receptors; Promoter Regions, Genetic; Retinoid X Receptors; Sterol Regulatory Element Binding Protein 1; Streptozocin; Transcriptional Activation | 2010 |
The influence of fasudil on the epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells from diabetic rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylglucosamine; Actins; Animals; beta Catenin; Blood Glucose; Cadherins; Cell Transdifferentiation; Creatinine; Diabetes Mellitus, Experimental; Epithelial Cells; Fibrosis; Kidney; Kidney Tubules; Male; Protein Phosphatase 1; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction | 2010 |
Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
Topics: Acetylglucosamine; Acylation; Animals; beta-N-Acetylhexosaminidases; Blotting, Western; Calcium; Calcium-Binding Proteins; Catecholamines; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; HeLa Cells; Humans; Immunoprecipitation; Male; Mutagenesis, Site-Directed; Mutation; Myocytes, Cardiac; N-Acetylglucosaminyltransferases; Oximes; Phenylcarbamates; Phosphorylation; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2010 |
Glucosamine treatment-mediated O-GlcNAc modification of paxillin depends on adhesion state of rat insulinoma INS-1 cells.
Topics: Acetylglucosamine; Actins; Animals; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Diabetes Mellitus, Experimental; Glucosamine; Humans; Immunohistochemistry; Insulinoma; Islets of Langerhans; Laminin; Mice; Mice, Inbred ICR; Microscopy, Fluorescence; Mutation; Paxillin; Phosphorylation; Rats; Serine; Streptozocin | 2010 |
Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats.
Topics: Acetylglucosamine; Administration, Oral; Animals; Apoptosis; bcl-2-Associated X Protein; Carnosine; Cytochromes c; Diabetes Mellitus, Experimental; Disease Models, Animal; Glycation End Products, Advanced; Kidney Glomerulus; Oxidative Stress; Podocytes; Rats; Rats, Wistar; Reactive Oxygen Species; Streptozocin | 2011 |
Alpha-lipoic acid preserves the structural and functional integrity of red blood cells by adjusting the redox disturbance and decreasing O-GlcNAc modifications of antioxidant enzymes and heat shock proteins in diabetic rats.
Topics: Acetylglucosamine; Animals; Antioxidants; Catalase; Diabetes Mellitus, Experimental; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Glutathione; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Iron; Lipid Peroxidation; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase; Thioctic Acid | 2012 |
Cardiac transcription factor Nkx2.5 is downregulated under excessive O-GlcNAcylation condition.
Topics: Acetylglucosamine; Acylation; Animals; Diabetes Mellitus, Experimental; Down-Regulation; Homeobox Protein Nkx-2.5; Homeodomain Proteins; Mice; Streptozocin; Transcription Factors | 2012 |
Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes.
Topics: Acetylation; Acetylglucosamine; Acetylglucosaminidase; Animals; Cytoplasm; Diabetes Complications; Diabetes Mellitus, Experimental; Dynamins; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria, Heart; Mitochondrial Diseases; Muscle Proteins; Myocytes, Cardiac; Phosphorylation; Protein Transport | 2012 |
Alpha-lipoic acid upregulates antioxidant enzyme gene expression and enzymatic activity in diabetic rat kidneys through an O-GlcNAc-dependent mechanism.
Topics: Acetylglucosamine; Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; DNA Damage; Glutathione; Glycosylation; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Hyperglycemia; Kidney; Kidney Diseases; Lipid Peroxidation; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Streptozocin; Superoxide Dismutase; Thioctic Acid; Up-Regulation | 2013 |
Heparan sulfate analysis from diabetic rat glomeruli.
Topics: Acetylglucosamine; Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disaccharides; Disease Models, Animal; Heparitin Sulfate; Kidney Glomerulus; Male; Oligosaccharides; Polysaccharide-Lyases; Rats; Rats, Sprague-Dawley; Sulfates | 2007 |
High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A.
Topics: Acetylglucosamine; Angiopoietin-2; Animals; Arginine; Cell Line, Transformed; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelial Cells; Gene Expression Regulation; Glucose; Glycolysis; Intercellular Adhesion Molecule-1; Kidney; Mice; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational; Pyruvaldehyde; Repressor Proteins; Response Elements; Sin3 Histone Deacetylase and Corepressor Complex; Sp3 Transcription Factor; Sweetening Agents; Transcription, Genetic; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2007 |
Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells.
Topics: Acetylglucosamine; Animals; Aorta, Thoracic; Capillaries; Cell Movement; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelial Cells; Female; Glucose; Glycosylation; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt; Tissue Culture Techniques | 2008 |
Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/db mouse.
Topics: Acetylglucosamine; Analysis of Variance; Animals; Bandages; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Skin; Wound Healing | 2008 |
Murine platelets are not regulated by O-linked beta-N-acetylglucosamine.
Topics: Acetylglucosamine; Animals; Blood Glucose; Blood Platelets; Blotting, Western; Diabetes Mellitus, Experimental; Disease Models, Animal; Mice; Mice, Inbred C57BL; Platelet Aggregation | 2008 |
O-GlcNAc regulates FoxO activation in response to glucose.
Topics: Acetylglucosamine; Animals; Catalase; Diabetes Mellitus, Experimental; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation; Glucose; Glucose-6-Phosphatase; Humans; Models, Biological; Nerve Tissue Proteins; Phosphoenolpyruvate Carboxykinase (ATP); Rats; Reactive Oxygen Species; Superoxide Dismutase | 2008 |
Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death.
Topics: Acetylglucosamine; Animals; Anti-Bacterial Agents; Apoptosis; Blood Glucose; Cell Death; Diabetes Mellitus, Experimental; Glucosamine; Glucose; Hyperglycemia; Immunohistochemistry; In Situ Hybridization; In Situ Nick-End Labeling; Islets of Langerhans; Mice; Mice, Transgenic; Pancreas; Rats; Rats, Sprague-Dawley; Streptozocin; Time Factors | 2000 |
The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Brain; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glycosylation; Islets of Langerhans; Rats; Rats, Sprague-Dawley; Streptozocin | 2001 |
Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.
Topics: Acetylglucosamine; Animals; Cattle; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Hyperglycemia; Immunoblotting; Membrane Potentials; Mutation; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oligonucleotides, Antisense; Phosphorylation; Plasmids; Protein Binding; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Recombinant Proteins; Superoxide Dismutase | 2001 |
Kinetic behaviour of liver glucokinase in diabetes. III. Possible role of insulinopenia.
Topics: Acetylglucosamine; Animals; Blood Glucose; Cytosol; Diabetes Mellitus, Experimental; Diazoxide; Female; Glucokinase; Glucose; Glycated Hemoglobin; Glycoproteins; Glycosylation; Insulin; Kinetics; Liver; Phosphorylation; Rats; Rats, Inbred Strains; Reference Values; Starvation; Substrate Specificity | 1990 |
Studies on glomerular basement membrane in experimental diabetes using lectin histochemistry in Wistar rats.
Topics: Acetylglucosamine; Animals; Basement Membrane; Diabetes Mellitus, Experimental; Glucosamine; Histocytochemistry; Kidney Glomerulus; Lectins; Male; Rats; Rats, Inbred Strains; Staining and Labeling; Wheat Germ Agglutinins | 1986 |
Lectin-ferritin binding on spontaneously diabetic and control rat retinal microvasculature.
Topics: Acetylglucosamine; Animals; Capillaries; Diabetes Mellitus, Experimental; Ferritins; Lectins; Microscopy, Electron; Plant Lectins; Rats; Rats, Inbred BB; Retinal Vessels; Trisaccharides; Wheat Germ Agglutinins | 1989 |
New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells.
Topics: 3-O-Methylglucose; Acetylglucosamine; Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Glucose; Hyperglycemia; Islets of Langerhans; Male; Methylglucosides; Rats; Rats, Inbred Strains; Streptozocin | 1986 |